3 and KP.3.1.1 wave, and with our predicted continued neutralization activity of pemivibart against the XEC variant, we are confident in the growth potential for PEMGARDA,” said Marc Elia, Chairman of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback